Document is current
Any future updates will be listed below
-
Authors
Dourron, Haley Maria https://orcid.org/0000-0002-1589-4081
Nichols, Charles D.
Simonsson, Otto
Bradley, Melissa
Carhart-Harris, Robin
Hendricks, Peter S.
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 29 November 2023
First Online: 11 December 2023
Declarations
:
: HMD and MS have no conflicts of interest. CDN is a co-founder and board member of 2A Biosciences, and has a Sponsored Research Agreement with 2A Biosciences. CDN is an advisor to Palo Santo. OS is a founder of Eudelics AB. RCH is a scientific advisor to Usona Institute, Synthesis Institute, Mydecine, Maya Health, Osmind, Entheos Labs, Beckley Psychtech, TRYP therapeutics, Journey Collab and Journey Space. PSH has been in paid advisory relationships with the following organizations regarding the development of psychedelics and related compounds: Bright Minds Biosciences Ltd., Eleusis Benefit Corporation, Journey Colab Corporation, Reset Pharmaceuticals Inc., and Silo Pharma. PSH has received research funding from the NIH and Heffter Research Institute.
